Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zizhong Yishen Wan
- Development stage
- Unknown
- Lead developer
- Beijing Boran Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Zizhong Yishen Wan is a Traditional Chinese Medicine (TCM) herbal product manufactured by Beijing Boran Pharmaceutical. It is formulated as an oral pill and is primarily used to tonify the kidney and replenish vital essence (Jing). In the context of TCM, it is indicated for symptoms associated with kidney deficiency, including soreness and weakness of the waist and knees, dizziness, tinnitus, and physical fatigue. As a complex herbal formulation, it does not have a single defined molecular mechanism of action but rather relies on the combined pharmacological effects of its constituent botanical ingredients. The product is an approved Chinese Patent Medicine (Zhongchengyao) marketed for renal and systemic health within the framework of traditional medicine.
- Brand names
- Zizhong Yishen Wan
- Other names
- 子仲益肾丸Zizhong Yishen Pills
02
Targets
JUN (Transcription factor Jun)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)TP53 (Cellular Tumor Antigen p53 R175H)ESR1 (ERα)IL-6 (Interleukin 6)
Beyond the preview
Go deeper on Zizhong Yishen Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zizhong Yishen Wan.